Post by marykudro on Nov 2, 2021 1:32:52 GMT -5
Tocilizumab is a monoclonal antibody of the immunoglobulin IgG1k category with an H2L2 polypeptide structure. Tocilizumab comes in the form of an intravenous injection to treat patients with rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis, cytokine release syndrome, etc.
Tocilizumab injection is administered by experienced healthcare professionals only. The active ingredients in the medicine are Tocilizumab, and the inactive ingredients are polysorbate 80, L-histidine and L-histidine monohydrochloride, L-arginine, and L-arginine hydrochloride, L-methionine, and water for injection.
Tocilizumab injection is administered by experienced healthcare professionals only. The active ingredients in the medicine are Tocilizumab, and the inactive ingredients are polysorbate 80, L-histidine and L-histidine monohydrochloride, L-arginine, and L-arginine hydrochloride, L-methionine, and water for injection.